Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic‐gland type: A retrospective, matched case–control study

Junnosuke Hayasaka,Shu Hoteya,Yutaka Takazawa,Daisuke Kikuchi,Akihiro Araki
DOI: https://doi.org/10.1111/jgh.16577
2024-04-22
Journal of Gastroenterology and Hepatology
Abstract:Background and Aim Since the first report of gastric adenocarcinoma of the fundic‐gland type in 2010, the clinicopathological characteristics of gastric neoplasm of the fundic‐gland type (GNFG) have become clearer; however, their risk factors remain unclear. This exploratory study aimed to identify the risk factors for GNFG. Methods We conducted a single‐center, retrospective, matched case–control study using medical information recorded at our health management center from January 2014 to July 2023. During this period, 39 240 people underwent upper gastrointestinal endoscopy. GNFG were extracted as cases and matched to controls, according to age and sex, in a 1:8 ratio, excluding those with a history of gastrointestinal surgery and those with a history or comorbidity of cancer. Univariate analysis was used to compare patient background and endoscopic findings. Multivariable analysis was performed, adjusting for factors with P values
gastroenterology & hepatology
What problem does this paper attempt to address?